Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2076 of 6351
-
Leg workouts may unlock a hidden cause of exercise intolerance in common heart failure
Disease control PausedHeart failure with preserved ejection fraction (HFpEF) accounts for approximately half of the heart failure population in the United States. The primary chronic symptom in patients with HFpEF is severe exercise intolerance quantified as reduced peak oxygen uptake during whole bod…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug shows promise for Hard-to-Treat cancers
Disease control OngoingThis study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is the first time the drug has been used in humans. There will be two parts and a sub-study. The primary purpose of the parts are: * Dose Escal…
Phase 1 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New cocktail of chemo drugs shows promise for tough pancreatic cancer
Disease control CompletedThe purpose of this study is to determine if the combination of paclitaxel protein bound, gemcitabine, cisplatin, paricalcitol are effective in individuals with previously untreated metastatic pancreatic cancer.
Phase 2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New cocktail of cancer drugs tested for Tough-to-Treat colorectal cancer
Disease control CompletedThe purpose of this study is to investigate treatment with nivolumab in combination with trametinib with or without ipilimumab in participants with previously treated cancer of the colon or rectum that has spread.
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Should HIV treatment start right away? new study tests timing
Disease control CompletedThe aim of this study is to compare the clinical response and mortality rate due to opportunistic disease in HIV-infected individuals who start immediate versus conventional antiretroviral therapy (ART). Immediate ART (iART) is defined as starting antiretroviral therapy within t…
Sponsor: Gustavo Reyes-Teran • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New program aims to help heart patients kick the habit and beat the blues
Disease control OngoingSummary of the Project : Quitting smoking following acute coronary syndrome (ACS) can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated…
Sponsor: Hennepin Healthcare Research Institute • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
New combo aims to stall advanced breast cancer
Disease control OngoingPembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
Phase 2 • Sponsor: Nancy Chan, MD • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for new moms: rapid brain zaps may ease Post-Partum depression
Symptom relief Recruiting nowStudy 1: The investigators are studying the feasibility and tolerability of 10x/day intermittent theta burst (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over the course of 6 days for women with post-partum depression. The investigator…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New radiation approach aims to safely treat Hard-to-Reach lung tumors
Disease control OngoingThis multi-centre phase I dose-escalation study will use a time-to-event continual reassessment method (TIT-CRM). Accrual will start at level 1 (60 Gy in 8 fractions). Patients will be assigned to treatment doses using the TITE-CRM model. The model will use all available informa…
Phase 1 • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 26, 2026 18:06 UTC
-
Brain blood flow fix may reverse thinking decline
Knowledge-focused CompletedWe aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery stenosis is reversible with restoration of flow. To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 tria…
Phase 3 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Can a 7th grade class stop dating violence before it starts?
Prevention CompletedThis study is a school-based trial of the 7th grade version of Fourth R, a promising teen dating violence prevention program, with 24 ethnically diverse middle schools in one of the nation's largest school districts to determine the impact of the program by comparing students in …
Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
MRI tailors radiation to throat cancer, aims to spare swallowing
Disease control OngoingThe goal of this clinical research study is to compare the use of MRI simulations to plan different doses of intensity modulated radiotherapy (IMRT) to the standard IMRT dose in patients with low risk human papilloma virus positive oropharyngeal cancer. This is an investigationa…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can aspirin timing stop colon cancer?
Prevention OngoingThis phase IIa trial studies how well aspirin works in preventing colorectal cancer in patients with colorectal adenoma. Aspirin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Virtual reality meditation tested as a tool to ward off hospital delirium
Symptom relief OngoingD.R.E.A.M.S. will assess an immersive digital reality-augmenting system in reducing the occurrence of cognitive, behavioral, and emotional consequences of critical illness and environmental exposures that are risk factors for the development of delirium.
Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo may beat BK virus in kidney transplants
Disease control CompletedBK virus nephropathy (BKVN), a consequence of the strong immunosuppressive therapy given after kidney transplantation, represents a growing problem in the kidney transplant (KT) setting. In recent cohorts, BKVN concerns up to 10% of kidney transplant recipients and early signs of…
Phase 4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Lupus drug benlysta proves safe and effective in large Real-World trial
Disease control CompletedThe objective of this study is to collect and assess the information about long-term safety and effectiveness of Benlysta for intravenous injection and Benlysta for subcutaneous injection (hereinafter referred to as "Benlysta") in daily clinical practice. The aim of conducting th…
Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Wearable gadget aims to retrain Stroke-Affected arms
Symptom relief Recruiting nowThe purpose of the study is to explore the feasibility of using a wearable device, called a myoelectric-computer interface (MCI), to improve arm movement in people who have had a stroke. Impaired arm movement after stroke is caused not just by weakness, but also by impaired coor…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Botox for stroke recovery: a tiny trial tests whether it can unlock a paralyzed arm
Symptom relief CompletedFollowing a stroke , 55% of the patients do not recover any traction of the upper limb and 30% a residual motricity not allowing a functional grip. For this last group of patients, there are major therapeutic issues to restore a functional grip. The aim of the study is to reliev…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug aims to slow vision loss in rare eye disease
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of avacincaptad pegol intravitreal injection compared to Sham in participants with autosomal recessive Stargardt disease 1 (STGD1).
Phase 2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New MRI technique may help personalize treatment for childhood eye cancer
Knowledge-focused Recruiting nowRetinoblastoma is the most frequent intraocular tumor in children and represents 6% of all pediatric cancers before the age of 5 years-old. The outcome is now excellent with 95 to 97% of 5-years survival rate. Conservative treatments are being more and more used, and intra arteri…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC